GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $64.82 $75.66 Friday, 19th Apr 2024 CYTK stock ended at $67.55. This is 0.82% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $64.82 to a day high of $67.80.
90 days $61.33 $84.92
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
2024-04-19 $66.88 $67.80 $64.82 $67.55 1 474 255
2024-04-18 $67.50 $68.53 $66.84 $67.00 862 385
2024-04-17 $69.58 $69.90 $67.88 $67.93 1 233 161
2024-04-16 $67.81 $70.52 $66.55 $69.00 946 053
2024-04-15 $71.60 $71.60 $67.48 $68.00 1 490 126
2024-04-12 $73.76 $73.76 $70.61 $71.56 789 372
2024-04-11 $74.99 $75.50 $72.39 $73.19 741 450
2024-04-10 $72.54 $74.94 $72.30 $74.36 803 120
2024-04-09 $74.20 $75.66 $73.43 $75.05 1 211 190
2024-04-08 $73.90 $74.38 $72.55 $74.19 953 333
2024-04-05 $69.21 $73.21 $68.43 $72.71 976 544
2024-04-04 $71.69 $72.31 $68.72 $69.18 715 558
2024-04-03 $70.27 $71.43 $70.00 $70.92 574 388
2024-04-02 $71.19 $72.72 $70.35 $70.97 997 255
2024-04-01 $69.78 $73.16 $68.90 $73.02 1 347 535
2024-03-28 $71.41 $71.86 $69.96 $70.11 1 611 905
2024-03-27 $71.40 $73.18 $69.88 $71.41 1 879 574
2024-03-26 $69.00 $74.67 $68.28 $71.15 3 998 598
2024-03-25 $67.75 $69.40 $67.64 $68.73 969 189
2024-03-22 $65.79 $68.33 $65.13 $67.42 1 411 838
2024-03-21 $67.90 $68.87 $65.77 $66.03 1 457 982
2024-03-20 $66.81 $67.96 $65.64 $67.36 1 445 580
2024-03-19 $63.64 $69.18 $63.41 $67.59 2 480 217
2024-03-18 $65.35 $68.35 $63.65 $63.75 2 008 455
2024-03-15 $63.43 $65.44 $62.37 $65.19 20 953 124
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT